# Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”

**Authors:** Elena Gerasimova, Tatiana V. Popkova, Irina G. Kirillova, Daria Gerasimova, Evgenii L. Nasonov, Aleksandr M. Lila

PMC · DOI: 10.3390/ijms26072953 · International Journal of Molecular Sciences · 2025-03-25

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** Atherosclerosis (MESH:D050197), Rheumatoid Arthritis (MESH:D001172)
- **Chemicals:** Tocilizumab (MESH:C502936)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11988665/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC11988665/full.md

---
Source: https://tomesphere.com/paper/PMC11988665